Again, increased expression of PEG10 was identified as a biomarker for shorter RFS when using the dataset based on localized PACa (HR = 3.0844; 95% CI, 1.397–6.812; p = 0.0053, for z-score ≥1; HR = 8.6811; 95% CI, 2.557–29.47; p = 0.0005, for z-score ≥1.5; and HR = 8.812; 95% CI, 2.01–38.63; p = 0.0039, for z-score ≥2). This evidence concerns the gene PEG10 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.